To help you discover the best supplements for your unique needs, we invite you to take our AI quiz
Among participants who reached week 12 without discontinuing, 87% achieved at least 15% weight loss by week 48
The STEP 1 clinical trial, published in the New England Journal of Medicine , found that once-weekly semaglutide produced an average body weight reduction of 14.9% over 68 weeks
Type 2 Diabetes: In the Lancet Phase 2 trial, retatrutide reduced HbA1c by up to 2.16 percentage points at the highest doses, accompanied by a robust weight reduction (~17% at 36 weeks)
however, some patients required continuation of anti-diabetic treatment despite discontinuation of the atypical antipsychotic drug
Boosting NAD + via the de novo pathway through Trp supplementation is not as popular, as quinolinic acid generated from Trp conversion is neurotoxic, and kynurenines have immunomodulatory roles 58